PARTNERING WITH OBSTETRICIANS TO IDENTIFY HEPATIC STEATOSIS IN PREGNANCY: A UNIQUE OPPORTUNITY FOR NON-ALCOHOLIC FATTY LIVER DISEASE DETECTION

被引：0
|
作者：
Lange, Marcia [1 ]
Rosenbluth, Emma [2 ]
Patel, Janki [3 ]
Meislin, Rachel [4 ]
Sperling, Rhoda [4 ]
Hussain, Farrah [5 ]
Stone, Joanne [4 ]
Argiriadi, Pamela [3 ]
Kushner, Tatyana [6 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY USA
[2] Northwestern Univ, Dept Med, Feinberg Sch Med, Evanston, IL USA
[3] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY USA
[4] Icahn Sch Med Mt Sinai, Dept Obstet & Gynecol, New York, NY USA
[5] Mt Sinai West Hosp, Dept Obstet & Gynecol, New York, NY USA
[6] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY USA
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3415
引用
收藏
页码：S1043 / S1043
页数：1
相关论文
共 50 条
  • [1] Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease
    Eremic-Kojic, N.
    Deric, M.
    Govorcin, M. L.
    Balac, D.
    Kresoja, M.
    Kojic-Damjanov, S.
    HIPPOKRATIA, 2018, 22 (01) : 10 - 16
  • [2] Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease
    Kojic, N. Eremic
    CLINICA CHIMICA ACTA, 2019, 493 : S362 - S362
  • [3] Controlled Attenuation Parameter (CAP) for the detection of hepatic steatosis in alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD)
    Naveau, Sylvie
    Perlemuter, Gabriel
    Ziol, Marianne
    Carmona, Damien
    Trinchet, Jean Claude
    Prevot, Sophie
    Nohra, Pascal
    Nguefang-Njike, Micheline Nakseu
    Beaugrand, Michel
    HEPATOLOGY, 2012, 56 : 898A - 898A
  • [4] Non-alcoholic fatty liver disease in pregnancy
    Benson, Charlotte S.
    Cobbold, Jeremy F.
    Frise, Charlotte J.
    OBSTETRIC MEDICINE, 2023, 16 (02) : 116 - 119
  • [5] Pathogenesis of hepatic steatosis:The link between hypercortisolism and non-alcoholic fatty liver disease
    Giovanni Tarantino
    Carmine Finelli
    World Journal of Gastroenterology, 2013, (40) : 6735 - 6743
  • [6] Role of exercise in the mechanisms ameliorating hepatic steatosis in non-alcoholic fatty liver disease
    Russell-Guzmán J.A.
    Karachon L.
    Gacitúa T.A.
    Freundlich A.
    Poblete-Aro C.E.
    Rodrigo R.
    Sport Sciences for Health, 2018, 14 (3) : 463 - 473
  • [7] Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk
    Drapkina, O. M.
    Korneeva, O. N.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (04) : 424 - 429
  • [8] Ticagrelor, but not clopidogrel, attenuated hepatic steatosis in a model of non-alcoholic fatty liver disease
    Oh, Hyunwoo
    Lee, Hyo Young
    Park, Huiyul
    Jun, Dae Won
    Yoon, Eileen
    Ahn, Sang Bong
    Lee, Chul-min
    Kim, Mi Mi
    Kang, Bo-Kyeong
    Sohn, Joo Hyun
    JOURNAL OF HEPATOLOGY, 2022, 77 : S728 - S729
  • [9] Pathogenesis of hepatic steatosis: The link between hypercortisolism and non-alcoholic fatty liver disease
    Tarantino, Giovanni
    Finelli, Carmine
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (40) : 6735 - 6743
  • [10] Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Nier, Anika
    Huber, Yvonne
    Labenz, Christian
    Michel, Maurice
    Bergheim, Ina
    Schattenberg, Joern M.
    NUTRIENTS, 2020, 12 (03)
12345